“…In the past three years, several electrochemical biosensors have been developed for detecting SARS-CoV-2 antigens based on diverse modified electrodes [25] , [26] , [27] , [28] , [29] . Despite such successes, the majority of these strategies either require sophisticated fabrication of an electrochemically responsive interface or synthesis of electroactive labels that link to bioreceptors [30] , [31] , or suffer from potential cross-reactivity of SARS-CoV-2 antibodies with antibodies generated against other coronaviruses due to their high genome similarities [32] , [33] , [34] , [35] . These drawbacks thereby result in potential tradeoffs in terms of sensitivity, specificity and user-friendliness.…”